In this study, sEVs with higher OGN levels at baseline were associated with slower disease progression and a better prognosis, raising the possibility that OGN in EVs in peripheral blood may have anti-ALS effects on neurons. The gene discussed is OGN; the disease is amyotrophic lateral sclerosis.